These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

734 related articles for article (PubMed ID: 35937991)

  • 21. Novel methylation-related long non-coding RNA clinical outcome prediction method: the clinical phenotype and immune infiltration research in low-grade gliomas.
    Li Y; Li X; Yu Z
    Front Oncol; 2023; 13():1177120. PubMed ID: 37228500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel peroxisome-related gene signature predicts clinical prognosis and is associated with immune microenvironment in low-grade glioma.
    Gao D; Zhou Q; Hou D; Zhang X; Ge Y; Zhu Q; Yin J; Qi X; Liu Y; Lou M; Zhou L; Bi Y
    PeerJ; 2024; 12():e16874. PubMed ID: 38406287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. m6A Regulators Is Differently Expressed and Correlated With Immune Response of Esophageal Cancer.
    Zhao H; Xu Y; Xie Y; Zhang L; Gao M; Li S; Wang F
    Front Cell Dev Biol; 2021; 9():650023. PubMed ID: 33748145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of m6A-Related Signatures in the Tumor Immune Microenvironment and Identification of Clinical Prognostic Regulators in Adrenocortical Carcinoma.
    Jin Y; Wang Z; He D; Zhu Y; Hu X; Gong L; Xiao M; Chen X; Cheng Y; Cao K
    Front Immunol; 2021; 12():637933. PubMed ID: 33746977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioinformatics analysis of the correlation between m6A RNA methylation regulators and the immune infiltration and prognosis of bladder cancer.
    Wu J; Wang X; Xu H; Tian J; Ji H; Zhu J; Guo H; Chen Z
    Ann Transl Med; 2022 Dec; 10(24):1386. PubMed ID: 36660722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. m6A RNA methylation regulators play an important role in the prognosis of patients with testicular germ cell tumor.
    Cong R; Ji C; Zhang J; Zhang Q; Zhou X; Yao L; Luan J; Meng X; Song N
    Transl Androl Urol; 2021 Feb; 10(2):662-679. PubMed ID: 33718069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of Genetic Alteration Signatures and Prognostic Values of m6A Regulatory Genes in Head and Neck Squamous Cell Carcinoma.
    Zhou X; Han J; Zhen X; Liu Y; Cui Z; Yue Z; Ding L; Xu S
    Front Oncol; 2020; 10():718. PubMed ID: 32547941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma.
    Xu Q; Xu H; Deng R; Li N; Mu R; Qi Z; Shen Y; Wang Z; Wen J; Zhao J; Weng D; Huang W
    Cancer Cell Int; 2021 Apr; 21(1):190. PubMed ID: 33794886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Iron Metabolism-Related Genes as Prognostic Indicators for Lower-Grade Glioma.
    Xu S; Wang Z; Ye J; Mei S; Zhang J
    Front Oncol; 2021; 11():729103. PubMed ID: 34568059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic, progressive and prognostic performance of m
    Zhuang Z; Chen L; Mao Y; Zheng Q; Li H; Huang Y; Hu Z; Jin Y
    Int J Biol Sci; 2020; 16(11):1785-1797. PubMed ID: 32398949
    [No Abstract]   [Full Text] [Related]  

  • 31. m6A-Related Genes Contribute to Poor Prognosis of Hepatocellular Carcinoma.
    Zou Y; Jiang G; Xie Y; Li H
    Comput Math Methods Med; 2022; 2022():2427987. PubMed ID: 36339682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimating the prognosis of esophageal squamous cell carcinoma based on The Cancer Genome Atlas (TCGA) of m6A methylation-associated genes.
    Pu Y; Lu X; Yang X; Yang Y; Wang D; Li M; Guan W; Xu M
    J Gastrointest Oncol; 2022 Feb; 13(1):1-12. PubMed ID: 35284129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of an m6A-Related Signature as Biomarker for Hepatocellular Carcinoma Prognosis and Correlates with Sorafenib and Anti-PD-1 Immunotherapy Treatment Response.
    Jiang H; Ning G; Wang Y; Lv W
    Dis Markers; 2021; 2021():5576683. PubMed ID: 34221187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploring the role of m6A methylation regulators in glioblastoma multiforme and their impact on the tumor immune microenvironment.
    Deng X; Sun X; Hu Z; Wu Y; Zhou C; Sun J; Gao X; Huang Y
    FASEB J; 2023 Sep; 37(9):e23155. PubMed ID: 37606566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The m6A/m5C/m1A regulator genes signature reveals the prognosis and is related with immune microenvironment for hepatocellular carcinoma.
    Liu T; Sun L; Li ZZ; Yang K; Chen JM; Han XY; Qi LM; Zhou XG; Wang P
    BMC Gastroenterol; 2023 May; 23(1):147. PubMed ID: 37170222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of the Role and Clinical Prognostic Value of Target Genes of m6A RNA Methylation Regulators in Glioma.
    Cong P; Wu T; Huang X; Liang H; Gao X; Tian L; Li W; Chen A; Wan H; He M; Dai D; Li Z; Xiong L
    Front Cell Dev Biol; 2021; 9():709022. PubMed ID: 34589481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive Analysis of m6A RNA Methylation Regulators in the Prognosis and Immune Microenvironment of Multiple Myeloma.
    Liu R; Shen Y; Hu J; Wang X; Wu D; Zhai M; Bai J; He A
    Front Oncol; 2021; 11():731957. PubMed ID: 34804925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of RBM15 as a prognostic biomarker in prostate cancer involving the regulation of prognostic m6A-related lncRNAs.
    Hu B; Lin D; Liu Z; Chen R; Liu J; Wu Y; Wang T
    Eur J Med Res; 2024 Aug; 29(1):411. PubMed ID: 39118157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment.
    Zhou H; Zheng M; Shi M; Wang J; Huang Z; Zhang H; Zhou Y; Shi J
    BMC Cancer; 2021 Aug; 21(1):938. PubMed ID: 34416861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and validation of a glioma prognostic model based on telomere-related genes and immune infiltration analysis.
    Liu X; Wang J; Su D; Wang Q; Li M; Zuo Z; Han Q; Li X; Zhen F; Fan M; Chen T
    Transl Cancer Res; 2024 Jul; 13(7):3182-3199. PubMed ID: 39145097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.